Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.
For more content, please subscribe to biotechblueprint.substack.com.
All content for Biotech Blueprint is the property of Katerina Roznik and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.
For more content, please subscribe to biotechblueprint.substack.com.
Subscribe to Biotech Blueprint at biotechblueprint.com In today's episode:How an Oxford-born, YC-backed startup is betting that cell-based production will define mRNA’s next decade.
Biotech Blueprint
Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.
For more content, please subscribe to biotechblueprint.substack.com.
